Otros idiomas IM Cannabis Corp. Nasdaq

Acciones

IMCC

CA44969Q3070

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 22/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,626 ^USD	-1,40 %		-11,84 %	+75,35 %

08/05	Transcript : IM Cannabis Corp., Q1 2024 Earnings Call, May 08, 2024
08/05	IM Cannabis Corp. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

IM Cannabis : Transcript	08/05
IM Cannabis : Financial Statements Q1 2024	08/05
IM Cannabis : Management's Discussion and Analysis Q1 2024	08/05
IM Cannabis Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	06/05
IM Cannabis Corp. and Vessel Brand, Inc. Partner to Bring Vessel Cannabis Accessories to the Israeli Market	09/04
IM Cannabis, Avant Brands Sign BLK MKT's Licensing Deal for German Medical Cannabis Market	04/04
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	04/04
IM Cannabis Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
IM Cannabis Corp. Brief: Notes This Provides IMC Germany with a "Unique Opportunity" to further accelerate growth in 2024 after delivering 180% growth in 2023	25/03
IM Cannabis Corp. Brief: Adds By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is Expected to deliver "Strong" growth	25/03
IM Cannabis Corp. Brief: Says Expects "Accelerated Growth" in Germany from that Country's "Groundbreaking" Cannabis Legalization	25/03
IM Cannabis Corp. Announces German Government's Final Approval of Legalizing Cannabis	25/03
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	06/03
IMC Announces Potential Reverse Merger With A Leading Clinical Cell Therapy Company	28/02
IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company	28/02
Kadimastem Ltd entered into a non-binding term sheet to acquire IM Cannabis Corp. in reverse merger transaction.	28/02
Avant Brands Brief: Restructuring Loan Agreements to Extend Term and Decrease Payments	26/02
IM Cannabis Brief: Says Received 180 Calendar Day Extension from Nasdaq Stock Market to Regain Compliance with Bid Price Rule	31/01
IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition	15/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas IM Cannabis Corp. Nasdaq

Acciones

IMCC

CA44969Q3070

Otros idiomas

Filtros